Autonomic Nervous System Drugs Practice Questions

Q: Which of the following is NOT an indication for the use of anticholinergics?

Glaucoma. **Explanation:** **1. Why Glaucoma is the Correct Answer:** Anticholinergics (like Atropine) cause **mydriasis** (dilation of the pupil) by blocking the M3 receptors on the sphincter pupillae. In patients with narrow-angle glaucoma, this causes the iris tissue to bunch up and block the canal of Schlemm, preventing the drainage of aqueous humor. This leads to a dangerous rise in intraocular pressure (IOP). Therefore, anticholinergics are strictly **contraindicated** in glaucoma. **2. Why the other options are incorrect (Indications):** * **Parkinsonism:** Centrally acting anticholinergics (e.g., **Benztropine, Trihexyphenidyl**) are used to restore the balance between dopamine and acetylcholine in the basal ganglia, specifically to treat drug-induced extrapyramidal symptoms. * **Refraction testing:** Anticholinergics cause **cycloplegia** (paralysis of the ciliary muscle), which is essential for accurate refraction testing in children to prevent accommodation from interfering with the measurement. * **Organophosphorus (OP) poisoning:** Atropine is the **specific antidote** for the muscarinic effects of OP poisoning. It competes with excess acetylcholine at the receptor sites to reverse life-threatening bradycardia and bronchosecretion. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for OP poisoning:** Atropine (titrated until "Atropinization" – drying of secretions and tachycardia). * **Shortest acting mydriatic:** Tropicamide (preferred for fundoscopy). * **Longest acting mydriatic:** Atropine (can last up to 7–10 days). * **Ipratropium/Tiotropium:** M3 blockers used via inhalation for COPD and Asthma. * **Glycopyrrolate:** Used pre-operatively to reduce salivary and tracheobronchial secretions.

Q: The main mechanism of hyperpyrexia induced by atropine includes:

Inhibition of sweating. **Explanation:** The correct answer is **B. Inhibition of sweating.** **Mechanism of Action:** Atropine is a competitive antagonist of muscarinic receptors. In the Autonomic Nervous System, sweat glands are innervated by **sympathetic cholinergic fibers** (an exception where sympathetic nerves release Acetylcholine onto M3 receptors). Atropine blocks these M3 receptors, leading to **anhidrosis** (suppression of sweat). Since evaporation of sweat is the primary physiological mechanism for heat loss in humans, its inhibition leads to a rapid rise in body temperature, known as **Atropine Fever**. **Analysis of Incorrect Options:** * **A. Vasodilation:** Atropine actually causes cutaneous vasodilation (Atropine flush) as a compensatory mechanism to dissipate heat when sweating fails, but this would theoretically lower temperature, not cause hyperpyrexia. * **C. Through central actions:** While atropine crosses the blood-brain barrier and can cause CNS excitation/delirium at high doses, the primary cause of hyperpyrexia is the peripheral failure of the thermoregulatory sweating mechanism. * **D. Increase in basal metabolic rate:** Atropine does not significantly alter the BMR; the temperature rise is due to decreased heat dissipation, not increased heat production. **Clinical Pearls for NEET-PG:** * **Atropine Poisoning Mnemonic:** "Hot as a hare (hyperpyrexia), Red as a beet (flushing), Dry as a bone (anhidrosis), Blind as a bat (mydriasis), Mad as a hatter (delirium)." * **Vulnerability:** Children are particularly susceptible to atropine-induced hyperpyrexia ("Atropine Fever"), even with small doses or ophthalmic drops. * **Antidote:** **Physostigmine** (a tertiary amine carbamate) is used for poisoning because it crosses the blood-brain barrier to reverse both central and peripheral effects.

Q: All of the following are true about atracurium, EXCEPT:

Histamine release is rare.. **Atracurium** is a benzylisoquinolinium neuromuscular blocking agent (NMBA) frequently tested in NEET-PG due to its unique metabolic pathway and side-effect profile. ### **Explanation of the Correct Answer** **Option D is the correct answer (the false statement)** because **histamine release is common** with atracurium, not rare. Atracurium belongs to the benzylisoquinolinium class, which is notorious for triggering non-immunological mast cell degranulation. This leads to clinical manifestations such as flushing, hypotension, and bronchospasm. ### **Analysis of Incorrect Options** * **Option A (Avoid in asthma):** Since atracurium causes significant histamine release, it can trigger bronchoconstriction. Therefore, it is generally avoided in patients with hyperreactive airways or bronchial asthma. * **Option B (Hofmann degradation):** This is a hallmark feature. Atracurium undergoes spontaneous non-enzymatic degradation at physiological pH and temperature. This makes it the drug of choice in patients with **liver or kidney failure**. * **Option C (Laudanosine toxicity):** Laudanosine is the major metabolite of atracurium. It is a CNS stimulant that can cross the blood-brain barrier and may lower the seizure threshold, potentially causing convulsions in high doses or prolonged infusions. ### **High-Yield Clinical Pearls for NEET-PG** * **Cisatracurium:** An isomer of atracurium that is more potent, undergoes Hofmann degradation, but importantly **does not cause histamine release**. * **Organ-Independent Elimination:** Both atracurium and cisatracurium are preferred in "multi-organ failure" because they do not rely on renal or hepatic clearance. * **Temperature/pH Sensitivity:** Since Hofmann degradation is temperature-dependent, the duration of action of atracurium is prolonged in patients with **hypothermia** or **acidosis**.

Q: What is the main metabolite of nicotine?

Cotinine. **Explanation:** **Cotinine** is the primary metabolite of nicotine [1], accounting for approximately **70-80%** of its metabolism. This conversion occurs primarily in the liver through the **Cytochrome P450 2A6 (CYP2A6)** enzyme system via a two-step process involving nicotine-Δ1'(5')-iminium ion. **Why Cotinine is the correct answer:** The clinical significance of cotinine lies in its **half-life**. While nicotine has a very short half-life (about 2 hours) [1], cotinine remains in the body much longer (half-life of **15–20 hours**). Consequently, cotinine levels in the blood, urine, or saliva are the "gold standard" biomarkers used to assess tobacco exposure and smoking status in clinical and forensic settings. **Analysis of Incorrect Options:** * **A. Nornicotine:** This is a minor metabolite (about 4%) and also a tobacco alkaloid found in the plant itself. It is not the "main" metabolite. * **B. Carboxynicotine:** This is not a recognized major metabolic pathway for nicotine in humans. * **D. Nicotine hydroxide:** This is not a standard metabolite; nicotine is primarily metabolized via C-oxidation (to cotinine) and N-oxidation [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Enzyme:** CYP2A6 is the chief enzyme responsible for nicotine metabolism. Genetic polymorphism in CYP2A6 can influence smoking behavior and lung cancer risk. * **Varenicline:** A partial agonist at $\alpha_4\beta_2$ nicotinic receptors used for smoking cessation. * **Bupropion:** An atypical antidepressant (NDRI) used to reduce nicotine withdrawal symptoms. * **Nicotine Toxicity:** Presents with the "SLUDGE" syndrome (cholinergic crisis) initially, followed by neuromuscular blockade. Management is symptomatic (Atropine for muscarinic effects).

Q: Which of the following drugs does not cross the blood-placental barrier?

Glycopyrrolate. **Explanation:** The transfer of drugs across the blood-placental barrier is primarily determined by the drug's molecular weight, lipid solubility, and ionization state. Drugs that are **highly ionized** and **polar** do not cross the placenta easily. **1. Why Glycopyrrolate is the Correct Answer:** Glycopyrrolate is a **quaternary ammonium compound**. Due to its quaternary structure, it is highly ionized and possesses low lipid solubility. This prevents it from crossing the blood-brain barrier (BBB) and, more importantly in this context, the **blood-placental barrier**. Therefore, it does not cause fetal tachycardia or other systemic effects in the fetus. **2. Why the Other Options are Incorrect:** * **Atropine, Physostigmine, and Hyoscine (Scopolamine):** These are all **tertiary amines**. Tertiary amines are non-ionized and highly lipid-soluble, allowing them to readily cross both the blood-brain barrier and the placental barrier. * **Atropine** is known to cause fetal tachycardia after maternal administration. * **Physostigmine** is the only anticholinesterase that crosses the BBB (used in atropine toxicity), unlike Neostigmine (a quaternary amine). **Clinical Pearls for NEET-PG:** * **Mnemonic "He Is Not Going":** Drugs that do **NOT** cross the placenta: **H**eparin, **I**nsulin, **N**eostigmine, **G**lycopyrrolate (also includes Succinylcholine and Vecuronium/Rocuranium). * **Anticholinesterases:** Neostigmine (quaternary) does not cross the placenta, but its counterpart Atropine (tertiary) does. This is why Glycopyrrolate is the preferred anticholinergic to pair with Neostigmine in obstetric reversals to maintain fetal heart rate stability. * Most anesthetic induction agents (Thiopentone, Propofol) and opioids **do** cross the placenta.

Q: Which of the following is a directly acting skeletal muscle relaxant?

Dantrolene. **Explanation:** The question tests the classification of skeletal muscle relaxants based on their site of action. **1. Why Dantrolene is Correct:** Dantrolene is the only **directly acting** skeletal muscle relaxant among the options. Unlike others that act at the neuromuscular junction (NMJ), Dantrolene acts intracellularly within the muscle fiber. It binds to the **Ryanodine Receptor (RyR1)** on the sarcoplasmic reticulum, inhibiting the release of calcium ions into the sarcoplasm. Since calcium is essential for excitation-contraction coupling, its blockade leads to muscle relaxation. **2. Why Other Options are Incorrect:** * **Suxamethonium (Succinylcholine):** It is a **depolarizing neuromuscular blocker**. It acts on the nicotinic receptors ($N_m$) at the NMJ, causing persistent depolarization of the motor endplate. * **Pancuronium & Atracurium:** These are **non-depolarizing (competitive) neuromuscular blockers**. They act by competing with Acetylcholine for the $N_m$ receptors at the NMJ, preventing muscle contraction. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** Dantrolene is the life-saving drug of choice for **Malignant Hyperthermia** (often triggered by Halothane or Suxamethonium) and **Neuroleptic Malignant Syndrome (NMS)**. * **Atracurium:** Notable for undergoing **Hofmann Elimination** (spontaneous non-enzymatic degradation), making it safe in patients with liver or kidney failure. * **Suxamethonium:** Associated with muscle fasciculations, hyperkalemia, and post-operative myalgia. It is metabolized by **pseudocholinesterase**.

Q: All of the following drugs are useful in detrusor instability except?

Duloxetine. **Explanation:** The question asks for the drug NOT used in **detrusor instability** (also known as **Overactive Bladder - OAB** or **Urge Incontinence**). **1. Why Duloxetine is the Correct Answer:** Duloxetine is a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) [4]. It is used in the management of **Stress Urinary Incontinence (SUI)**, not urge incontinence. It works by increasing the tone of the external urethral sphincter via stimulation of Onuf’s nucleus in the sacral spinal cord. In detrusor instability, the problem is an overactive bladder muscle; Duloxetine does not relax the detrusor. **2. Analysis of Incorrect Options:** * **Solifenacin & Tolterodine:** These are **M3-selective muscarinic antagonists** [1]. Since bladder contraction is mediated by M3 receptors, these drugs are the first-line pharmacological treatment for detrusor instability as they promote bladder relaxation and increase capacity [1], [2]. * **Flavoxate:** This is a tertiary amine with **antispasmodic** properties [3]. It exerts a direct relaxant effect on the smooth muscle of the urinary tract and is indicated for symptomatic relief of bladder spasms [3]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for OAB:** Oxybutynin (non-selective) or Darifenacin/Solifenacin (M3 selective) [2]. * **Mirabegron:** A **Beta-3 (β3) agonist** used for OAB; it relaxes the detrusor muscle during the storage phase. * **Stress Incontinence:** Characterized by leakage during coughing/sneezing. Treatment includes pelvic floor exercises (Kegel's) and Duloxetine. * **Urge Incontinence:** Characterized by a sudden, intense urge to void. Treatment focuses on anticholinergics [1].

Q: A patient with glaucoma and bronchial asthma presents with status asthmaticus. What causative agent might have precipitated this condition?

Timolol eye drop. **Explanation:** **1. Why Timolol is the Correct Answer:** Timolol is a **non-selective beta-blocker** ($\beta_1$ and $\beta_2$ antagonist) commonly used as first-line therapy for glaucoma to decrease aqueous humor production. Even when administered topically as eye drops, significant systemic absorption occurs via the nasolacrimal duct, bypassing first-pass metabolism. In patients with pre-existing bronchial asthma, the blockade of $\beta_2$ receptors in the bronchial smooth muscle leads to bronchoconstriction, which can precipitate life-threatening **status asthmaticus**. **2. Analysis of Incorrect Options:** * **Pilocarpine (Option A):** A direct-acting cholinergic agonist (miotic). While it can cause bronchoconstriction in theory, it is not a beta-blocker and is rarely associated with precipitating status asthmaticus compared to $\beta$-blockers. * **Betaxolol (Option C):** This is a **cardioselective ($\beta_1$) blocker**. Because it lacks significant $\beta_2$ antagonist activity, it is the safest beta-blocker for glaucoma patients who also have respiratory diseases (though it should still be used with caution). * **Levobunolol (Option D):** Like timolol, it is a non-selective beta-blocker. However, Timolol is the classic prototype and the most frequently cited agent in exam questions regarding this specific adverse interaction. **3. NEET-PG High-Yield Pearls:** * **Systemic Absorption:** To minimize systemic side effects of eye drops, patients should be taught **nasolacrimal occlusion** (pressing the inner canthus) for 1–2 minutes after instillation. * **Drug of Choice:** For a glaucoma patient with asthma, **Betaxolol** is the preferred beta-blocker, or alternative classes like Prostaglandin analogues (Latanoprost) should be used. * **Contraindications for Timolol:** Asthma, COPD, Bradycardia, and Second/Third-degree heart block.

Question 1

Which of the following is NOT an indication for the use of anticholinergics?

Accepted Answer

Glaucoma

Answer

Parkinsonism

Answer

Refraction testing

Answer

Organophosphorus poisoning

Question 2

True about pilocarpine?

Accepted Answer

It is the drug of choice for treatment of angle-closure glaucoma

Answer

It acts by decreasing secretion from ciliary epithelium

Answer

Side effects include bitter taste and renal calculi

Answer

It is a hyperosmotic agent

Question 3

The main mechanism of hyperpyrexia induced by atropine includes:

Accepted Answer

Inhibition of sweating

Answer

Vasodilation

Answer

Through central actions

Answer

Increase in basal metabolic rate

Question 4

All of the following are true about atracurium, EXCEPT:

Accepted Answer

Histamine release is rare.

Answer

Should be avoided in asthmatic patients.

Answer

Metabolism is by Hofmann degradation.

Answer

Laudanosine toxicity is present.

Question 5

What is the main metabolite of nicotine?

Accepted Answer

Cotinine

Answer

Nornicotine

Answer

Carboxynicotine

Answer

Nicotine hydroxide

Question 6

Which of the following drugs does not cross the blood-placental barrier?

Accepted Answer

Glycopyrrolate

Answer

Atropine

Answer

Physostigmine

Answer

Hyoscine hydrobromide

Question 7

Which one of the following drugs is not a reversible anticholinesterase drug?

Accepted Answer

Carbaryl

Answer

Edrophonium

Answer

Demecarium

Answer

Twine

Question 8

Which of the following is a directly acting skeletal muscle relaxant?

Accepted Answer

Dantrolene

Answer

Suxamethonium

Answer

Pancuronium

Answer

Atracurium

Question 9

All of the following drugs are useful in detrusor instability except?

Accepted Answer

Duloxetine

Answer

Solefenacin

Answer

Tolterodine

Answer

Flavoxate

Question 10

A patient with glaucoma and bronchial asthma presents with status asthmaticus. What causative agent might have precipitated this condition?

Accepted Answer

Timolol eye drop

Answer

Pilocarpine eye drop

Answer

Betaxolol eye drop

Answer

Levobunolol eye drop

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?